What type of study is this?

October 27, 2025Current Medicinal Chemistry

Antitumor and Immunoregulatory Effects of Curcumin Analog, (Z)-3-Hydroxy-1-(2-hydroxyphenyl)-3-phenyl prop-2-ene-1-one (DK1), on CT26-Tumor-Bearing BALB/c Mi

View Full Paper

Ask AI

Bookmark

Authors

YHYazmin HussinUniversiti Putra Malaysia NRNurul Fattin Che RahimUniversiti Putra Malaysia MAMuhammad Nazirul Mubin AzizAIMST University

Discussion

Member takes

Implication

Antitumor effects of curcumin analog DK1 reduce tumor growth and regulate inflammation in colon cancer models, indicating its potential as an immunomodulatory agent.

Key Points

DK1 treatment reduced tumor volume and increased apoptotic tumor cells in colon cancer.
IL-1β expression was decreased significantly, alongside observed changes in immunophenotyping.
In vivo analysis utilized BALB/c mice that were induced to develop colon cancer for treatment assessment.
Findings may support DK1 as a promising candidate for future immunomodulatory therapies against cancer.

Cite This Study

Hussin et al. (2025) studied this question.

synapsesocial.com/papers/68ff87d8c8c50a61f2bdcc2d https://doi.org/10.2174/0109298673396217251003070048

View Full Paper

Ask AI

Bookmark

Implication

Antitumor effects of curcumin analog DK1 reduce tumor growth and regulate inflammation in colon cancer models, indicating its potential as an immunomodulatory agent.

Antitumor and Immunoregulatory Effects of Curcumin Analog, (Z)-3-Hydroxy-1-(2-hydroxyphenyl)-3-phenyl prop-2-ene-1-one (DK1), on CT26-Tumor-Bearing BALB/c Mi

Discussion

Member takes

Implication

Key Points

Cite This Study

Antitumor and Immunoregulatory Effects of Curcumin Analog, (Z)-3-Hydroxy-1-(2-hydroxyphenyl)-3-phenyl prop-2-ene-1-one (DK1), on CT26-Tumor-Bearing BALB/c Mi

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider